Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

TELA Bio, Inc. (TELA) had Revenue of $19.29M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$19.29M
Net Income	$-11.26M
Cost of Goods Sold	$5.25M
Gross Profit	$14.04M
Operating Expenses	$28.57M
Operating Income	$-9.28M
Non-Operating Income/Expense	$-1.92M
Pre-Tax Income	$-11.20M
Normalized Pre-Tax Income	$-11.20M
Income after Taxes	$-11.26M
Income from Continuous Operations	$-11.26M
Consolidated Net Income/Loss	$-11.26M
Normalized Income after Taxes	$-11.26M
EBIT	$-9.28M
EBITDA	$-9.02M
Weighted-Average Shares Outstanding (Basic)	57.41M
Weighted-Average Shares Outstanding (Diluted)	57.41M
Earnings per Share (EPS) (Basic)	$-0.20
Earnings per Share (EPS) (Diluted)	$-0.20
Balance Sheet Financials
Current Assets	$54.49M
Property, Plant, and Equipment	$2.05M
Long-Term Assets	$5.25M
Total Assets	$59.74M
Current Liabilities	$18.22M
Long-Term Debt	$56.08M
Long-Term Liabilities	$57.39M
Total Liabilities	$75.60M
Common Equity	$-15.87M
Tangible Shareholders Equity	$-17.04M
Shareholders Equity	$-15.87M
Common Shares Outstanding	44.83M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-20.55M
Cash Flow from Investing Activities	$0.43M
Cash Flow from Financial Activities	$-0.31M
Beginning Cash	$51.09M
End Cash	$30.62M
Increase/Decrease in Cash	$-20.47M
Stock-Based Compensation	$1.43M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.99
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.39
Debt to Equity Ratio	-3.53
Gross Margin	72.77%
Operating Margin	-48.12%
EBIT Margin	-48.12%
EBITDA Margin	--
Pre-Tax Profit Margin	-58.07%
Profit Margin	-58.38%
Free Cash Flow	$-20.73M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.32
Inventory Turnover	0.47
Receiveable Turnover	2.00
Days Sales in Receivables	44.96
Return on Equity	70.98%
Return on Tangible Equity	66.11%
Return on Assets	-18.85%
Return on Investments	-28.00%
Book Value Per Share	$-0.35
Free Cash Flow per Share	$-0.36
Operating Cash Flow per Share	$-0.36

Data from Zacks Investment Research, Inc.